Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ADPT | Adaptive Biotechnologies Corporation

Index	RUT	P/E	-	EPS (ttm)	-1.33	Insider Own	0.20%	Shs Outstand	144.40M	Perf Week	-16.34%
Market Cap	751.48M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	-47.17%	Shs Float	141.96M	Perf Month	-22.00%
Income	-190.90M	PEG	-	EPS next Q	-0.33	Inst Own	89.30%	Short Float / Ratio	7.33% / 8.83	Perf Quarter	-26.95%
Sales	189.60M	P/S	3.96	EPS this Y	4.90%	Inst Trans	-3.03%	Short Interest	10.41M	Perf Half Y	-35.33%
Book/sh	2.74	P/B	1.85	EPS next Y	17.90%	ROA	-23.20%	Target Price	11.88	Perf Year	-31.49%
Cash/sh	2.81	P/C	1.80	EPS next 5Y	21.60%	ROE	-43.10%	52W Range	4.95 - 10.79	Perf YTD	-33.64%
Dividend	-	P/FCF	-	EPS past 5Y	-31.30%	ROI	-43.10%	52W High	-53.01%	Beta	1.26
Dividend %	-	Quick Ratio	4.80	Sales past 5Y	37.00%	Gross Margin	64.10%	52W Low	2.42%	ATR	0.36
Employees	790	Current Ratio	5.00	Sales Q/Q	11.90%	Oper. Margin	-	RSI (14)	29.41	Volatility	7.29% 5.76%
Optionable	Yes	Debt/Eq	0.32	EPS Q/Q	9.40%	Profit Margin	-	Rel Volume	1.07	Prev Close	5.18
Shortable	Yes	LT Debt/Eq	0.32	Earnings	Aug 02 AMC	Payout	-	Avg Volume	1.18M	Price	5.07
Recom	2.10	SMA20	-18.25%	SMA50	-25.01%	SMA200	-34.24%	Volume	1,259,376	Change	-2.12%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Overweight	$15
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$15
Dec-21-22	Upgrade	Piper Sandler	Neutral → Overweight	$7.50 → $14
Aug-25-22	Initiated	Credit Suisse	Underperform	$8
Jun-03-22	Initiated	Piper Sandler	Neutral	$7.50
Feb-16-22	Reiterated	JP Morgan	Overweight	$75 → $50
Feb-16-22	Reiterated	Goldman	Neutral	$54 → $21
Feb-16-22	Reiterated	BTIG Research	Buy	$35 → $30
Feb-16-22	Reiterated	BofA Securities	Buy	$40 → $32
Oct-15-21	Resumed	Cowen	Outperform
Mar-03-21	Downgrade	Goldman	Buy → Neutral	$74 → $63
Oct-08-20	Resumed	BTIG Research	Buy	$60
Sep-09-20	Initiated	Morgan Stanley	Equal-Weight	$42
Jun-03-20	Initiated	Goldman	Buy	$60
Jul-23-19	Initiated	BTIG Research	Buy	$46
Jul-22-19	Initiated	William Blair	Outperform
Jul-22-19	Initiated	Guggenheim	Buy	$47
Jul-22-19	Initiated	Goldman	Neutral	$32
Jul-22-19	Initiated	Cowen	Outperform
Jul-22-19	Initiated	BofA/Merrill	Buy	$45

Show Previous Ratings

Sep-13-23 07:30AM	Adaptive Announces Launch of Epic Integration for clonoSEQ® (GlobeNewswire)
Aug-30-23 04:30PM	Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-28-23 11:53PM	3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List (InvestorPlace)
Aug-24-23 10:29AM	Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks (Motley Fool) -6.62%
Aug-02-23 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:30PM	Loading…
04:30PM	Adaptive Biotechnologies: Q2 Earnings Snapshot (AP Finance)
04:05PM	Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-29-23 12:12AM	Is it Still Worthy to Invest in Adaptive Biotechnologies (ADPT)? (Insider Monkey)
Jul-19-23 08:52AM	Viking Globals Performance, AUM, and Long-Term Stock Picks (Insider Monkey)
Jul-10-23 04:05PM	Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023 (GlobeNewswire) +8.28%
Jun-24-23 03:19PM	11 Best Medical Stocks Under $10 (Insider Monkey)
Jun-16-23 05:02PM	Why Shares of Adaptive Biotechnologies Jumped This Week (Motley Fool)
Jun-02-23 10:15AM	Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought (Motley Fool) +5.82%
07:34AM	Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assays Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer (GlobeNewswire)
May-29-23 08:08AM	Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss (Simply Wall St.)
09:45AM	Loading…
May-26-23 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
May-24-23 04:05PM	Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences (GlobeNewswire) +6.42%
May-23-23 09:54AM	Too Cheap to Ignore: Cathie Wood Snaps Up These 2 Stocks Under $10 (TipRanks)
May-15-23 07:50AM	3 Personalized Medicine Stocks to Buy for Long-Time Returns (InvestorPlace)
May-12-23 08:00AM	Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-09-23 07:30AM	Adaptive Biotechnologies Announces FDA Acceptance of Genentechs Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology (GlobeNewswire) +6.21%
May-04-23 09:13AM	Q1 2023 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents) -14.27%
May-03-23 05:25PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.99%
04:05PM	Adaptive Biotechnologies Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 10:02AM	Analysts Estimate Blueprint Medicines (BPMC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-26-23 10:02AM	Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-25-23 04:05PM	Adaptive Biotechnologies to Participate in the BofA Securities 2023 Healthcare Conference (GlobeNewswire) -9.82%
Apr-24-23 09:40AM	Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Apr-18-23 12:10PM	Investors Still Waiting For A Pull Back In Adaptive Biotechnologies Corporation (NASDAQ:ADPT) (Simply Wall St.)
Apr-12-23 07:30AM	Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline (GlobeNewswire)
04:05PM	Loading…
Apr-06-23 04:05PM	Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023 (GlobeNewswire)
Mar-29-23 04:20PM	11 Most Promising Gene Editing Stocks According to Analysts (Insider Monkey)
Mar-27-23 09:40AM	Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-16-23 11:41AM	Bellicum (BLCM) Down on Ending Development of CAR-T Candidates (Zacks)
Mar-10-23 10:42AM	Neoleukin (NLTX) Up 36% on Initiating Another Restructuring Plan (Zacks)
10:26AM	AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies (Zacks)
Mar-09-23 09:55AM	How Much Upside is Left in Adaptive Biotechnologies (ADPT)? Wall Street Analysts Think 49.94% (Zacks) -7.54%
09:40AM	Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year? (Zacks)
Feb-28-23 11:11AM	Perrigo (PRGO) Beats Q4 Earnings Estimates, Lags on Sales (Zacks)
Feb-27-23 04:05PM	Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-24-23 11:52AM	Karuna (KRTX) Reports Narrower-Than-Expected Loss in Q4 (Zacks)
Feb-21-23 09:55AM	Can Adaptive Biotechnologies (ADPT) Climb 45.58% to Reach the Level Wall Street Analysts Expect? (Zacks) -7.37%
09:40AM	Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-14-23 05:55PM	Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Jan-30-23 07:21AM	Companies Like Adaptive Biotechnologies (NASDAQ:ADPT) Are In A Position To Invest In Growth (Simply Wall St.)
Jan-23-23 04:05PM	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023 (GlobeNewswire)
Jan-10-23 09:00AM	Capella Space Raises $60M in Growth Equity from the United States Innovative Technology Fund to Expand Satellite Imaging Capacity and Meet Rapidly Growing Customer Demand (PR Newswire)
Dec-27-22 04:05PM	Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-22 06:14AM	Adaptive Biotechnologies (NASDAQ:ADPT shareholders incur further losses as stock declines 17% this week, taking three-year losses to 76% (Simply Wall St.)
Dec-10-22 10:00AM	Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting (GlobeNewswire)
Dec-05-22 07:30AM	Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting (GlobeNewswire) -7.92%
Dec-01-22 07:30AM	Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA) (GlobeNewswire)
Nov-21-22 04:05PM	Adaptive Biotechnologies to Participate in the Piper Sandler Healthcare Conference (GlobeNewswire)
07:30AM	New Survey Reveals the Majority of Myeloma Patients That Undergo Minimal Residual Disease (MRD) Testing Find a Clear Clinical or Emotional Benefit from Results (GlobeNewswire)
Nov-03-22 06:35PM	Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-11-22 08:05AM	Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers (GlobeNewswire)
Oct-05-22 04:05PM	Adaptive Biotechnologies to Report Third Quarter of 2022 Financial Results on November 3, 2022 (GlobeNewswire)
Sep-15-22 06:48AM	Institutional owners may consider drastic measures as Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) recent US$104m drop adds to long-term losses (Simply Wall St.)
Sep-14-22 05:22PM	Adaptive Biotechnologies to receive up to $250M in financing deal (American City Business Journals)
Sep-12-22 08:30AM	Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million (GlobeNewswire)
Sep-02-22 08:00AM	Adaptive Biotechnologies to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-14-22 11:13AM	3 Cathie Wood Stocks for the Future (Motley Fool)
Aug-04-22 12:00AM	Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript (Motley Fool) +14.86%
Aug-03-22 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 10:07AM	Is a Surprise Coming for Adaptive Biotechnologies (ADPT) This Earnings Season? (Zacks)
Jul-28-22 10:02AM	Earnings Preview: NGM Biopharmaceuticals (NGM) Q2 Earnings Expected to Decline (Zacks)
09:48AM	Cathie Woods Top 15 Small-Cap Stock Picks (Insider Monkey)
07:30AM	Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma (GlobeNewswire)
Jul-27-22 10:01AM	Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-18-22 06:56AM	Here's Why We're Watching Adaptive Biotechnologies' (NASDAQ:ADPT) Cash Burn Situation (Simply Wall St.) -6.09%
Jul-08-22 04:05PM	Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022 (GlobeNewswire)
09:08AM	10 Small-Cap Growth Stocks in Cathie Woods Portfolio (Insider Monkey)
Jun-16-22 12:49PM	Microsoft-Developed Covid Tech Can Now Detect Lyme Disease (TheStreet.com)
Jun-15-22 07:30AM	Adaptive Biotechnologies Launches T-Detect Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease (GlobeNewswire) +11.02%
Jun-10-22 05:00PM	ASCO 2022: Surprising News in Cancer Research (Motley Fool) -7.07%
Jun-03-22 10:09AM	Even after rising 5.5% this past week, Adaptive Biotechnologies (NASDAQ:ADPT) shareholders are still down 78% over the past year (Simply Wall St.) -13.14%
Jun-02-22 04:10PM	Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology (GlobeNewswire) +9.45%
May-31-22 11:42AM	Is Adaptive Biotechnologies (ADPT) a Worthy Investment Choice? (Insider Monkey)
May-26-22 08:00AM	Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences (GlobeNewswire)
May-13-22 10:35AM	10 Amazing Stocks Under $10 (Part II) (Motley Fool) +19.77%
May-04-22 10:30PM	Adaptive Biotechnologies Corporation (ADPT) Q1 2022 Earnings Call Transcript (Motley Fool)
06:35PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports First Quarter 2022 Financial Results (GlobeNewswire)
09:59AM	Is Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Trading At A 50% Discount? (Simply Wall St.)
May-02-22 04:05PM	Adaptive Biotechnologies to Present at the BofA Securities 2022 Healthcare Conference (GlobeNewswire)
Apr-05-22 04:30PM	Adaptive Biotechnologies to Report First Quarter Financial Results on May 4, 2022 (GlobeNewswire) -6.74%
Mar-31-22 11:16AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
05:46AM	Cathie Wood Can't Get Enough of These 2 Biotech Stocks (Motley Fool)
Mar-25-22 04:54PM	How Many Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Shares Do Institutions Own? (Simply Wall St.)
01:24PM	Cathie Wood Buys Into a Biotech With a Covid Connection (TheStreet.com)
Mar-22-22 10:10AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) +5.38%
Mar-11-22 12:43PM	10 Stock Picks of Julian Robertsons Tiger Management (Insider Monkey) -8.41%
Mar-10-22 10:15AM	Adaptive Biotechnologies (ADPT) Rises on Restructuring Plans (Zacks) -6.32%
Mar-09-22 10:37AM	Adaptive Biotechnologies To Lay Off ~12% Of Its Workforce, Names Tycho Peterson As CFO (Benzinga) +9.57%
07:00AM	Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas (GlobeNewswire)
01:34AM	Adaptive Biotechnologies laying off 100 employees in organizational shakeup (American City Business Journals)
Mar-02-22 04:05PM	Adaptive Biotechnologies to Present at the 42nd Annual Cowen Healthcare Conference (GlobeNewswire) -6.04%

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer and autoimmune disorders. It offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SOOD NITIN	Chief Commercial Officer, MRD	Aug 08	Sale	6.54	10,550	68,997	214,808	Aug 08 04:53 PM
SOOD NITIN	Chief Commercial Officer, MRD	Aug 07	Sale	6.78	5,652	38,321	225,358	Aug 08 04:53 PM
PETERSON TYCHO	Chief Financial Officer	Jun 20	Option Exercise	7.30	134,961	985,215	534,180	Jun 21 05:32 PM
PETERSON TYCHO	Chief Financial Officer	Jun 20	Sale	8.14	134,961	1,098,583	399,219	Jun 21 05:32 PM
PETERSON TYCHO	Chief Financial Officer	Jun 15	Option Exercise	7.30	14,328	104,594	413,547	Jun 20 05:41 PM
PETERSON TYCHO	Chief Financial Officer	Jun 15	Sale	8.53	70,000	597,100	399,219	Jun 20 05:41 PM
PETERSON TYCHO	Chief Financial Officer	Jun 02	Sale	7.16	38,000	272,080	454,891	Jun 06 04:23 PM
ADAMS R MARK	Chief Operating Officer	Apr 11	Sale	8.63	2,308	19,918	175,361	Apr 12 06:04 PM
ADAMS R MARK	Chief Operating Officer	Apr 10	Sale	8.50	817	6,944	177,669	Apr 12 06:04 PM
GRIFFIN MICHELLE RENEE	Director	Mar 27	Sale	8.49	2,341	19,878	20,627	Mar 29 05:01 PM
ADAMS R MARK	Chief Operating Officer	Mar 07	Sale	8.60	17,155	147,533	178,486	Mar 08 08:03 PM
Taylor Stacy L	SVP and General Counsel	Mar 07	Sale	8.60	13,387	115,128	139,678	Mar 08 08:04 PM
SOOD NITIN	Chief Commercial Officer, MRD	Mar 07	Sale	8.60	9,813	84,392	231,010	Mar 08 08:01 PM
RUBINSTEIN JULIE	President	Mar 06	Sale	8.57	22,668	194,265	336,824	Mar 08 08:01 PM
BENZENO SHARON	Chief Commercial Ofc Imm Med	Mar 06	Sale	8.57	11,749	100,689	223,826	Mar 08 08:02 PM
LO FRANCIS	Chief People Officer	Mar 06	Sale	8.57	6,816	58,413	168,469	Mar 08 08:04 PM
SOOD NITIN	Chief Commercial Officer, MRD	Mar 06	Sale	8.57	6,661	57,085	240,823	Mar 08 08:01 PM
ADAMS R MARK	Chief Operating Officer	Mar 06	Sale	8.57	6,529	55,954	195,641	Mar 08 08:03 PM
Taylor Stacy L	SVP and General Counsel	Mar 06	Sale	8.57	5,491	47,058	153,065	Mar 08 08:04 PM
PISKEL KYLE	Principal Accounting Officer	Mar 06	Sale	8.57	3,529	30,246	87,564	Mar 08 08:04 PM
HERSHBERG ROBERT	Director	Feb 02	Option Exercise	0.45	53,000	23,850	61,193	Feb 03 05:00 PM
ADAMS R MARK	Chief Operating Officer	Jan 10	Sale	8.58	2,130	18,275	113,518	Jan 11 06:00 PM
ADAMS R MARK	Chief Operating Officer	Jan 09	Sale	8.50	995	8,458	115,648	Jan 11 06:00 PM
PISKEL KYLE	Principal Accounting Officer	Nov 16	Sale	8.87	959	8,506	46,706	Nov 17 06:00 AM
SOOD NITIN	Chief Commercial Officer, MRD	Nov 01	Sale	8.00	31,066	248,528	114,505	Nov 01 09:00 PM
ADAMS R MARK	Chief Operating Officer	Oct 10	Sale	7.13	2,284	16,285	116,643	Oct 11 06:00 PM
ADAMS R MARK	Chief Operating Officer	Oct 07	Sale	7.61	841	6,400	118,927	Oct 11 06:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADPT | Adaptive Biotechnologies Corporation

Upgrade your FINVIZ experience